Postoperative outcomes and recurrence patterns of intermediate-stage hepatocellular carcinoma dictated by the sum of tumor size and number

doi:10.3748/wjg.v28.i44.6271

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 28, Issue 44

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4530)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-3) series.

Item

Count

PDF

184

WORD

HTML

1963

Figures (1-3)

400

Tables (1-3)

384

Sum=2969

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

346

Download

1215

Sum=1561

Nov 28, 2022 (publication date) through Dec 12, 2024

Times Cited of This Article

Times Cited (2)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Gastroenterol. Nov 28, 2022; 28(44): 6271-6281
Published online Nov 28, 2022. doi: 10.3748/wjg.v28.i44.6271

Full Size Figure Download Figure

Figure 2 Comparison of overall survival and recurrence-free survival in multinodular hepatocellular carcinoma patients with Barcelona Clinic Liver Cancer stage A, B1 and B2. A: overall survival; B: recurrence-free survival. BCLC: Barcelona Clinic Liver Cancer; MNHCC: Multinodular hepatocellular carcinoma.

Citation: Hu XS, Yang HY, Leng C, Zhang ZW. Postoperative outcomes and recurrence patterns of intermediate-stage hepatocellular carcinoma dictated by the sum of tumor size and number. World J Gastroenterol 2022; 28(44): 6271-6281
URL: https://www.wjgnet.com/1007-9327/full/v28/i44/6271.htm
DOI: https://dx.doi.org/10.3748/wjg.v28.i44.6271